University of California - San Diego

Tumor-activated protein promotes cancer spread

Researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center report that cancers physically alter cells in the lymphatic system – a network of vessels that transports and ...

May 13, 2013
popularity 4.2 / 5 (5) | comments 0 | with audio podcast

Fractalkine: New protein target for controlling diabetes

Researchers at the University of California, San Diego School of Medicine have identified a previously unknown biological mechanism involved in the regulation of pancreatic islet beta cells, whose role is to produce and release ...

Apr 11, 2013
popularity not rated yet | comments 0 | with audio podcast

Engineered small pox may kill liver cancer

As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec ...

Apr 10, 2013
popularity 5 / 5 (2) | comments 0

Monoclonal antibody targets, kills leukemia cells

Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

Mar 25, 2013
popularity 5 / 5 (5) | comments 0 | with audio podcast